var data={"title":"Cradle cap and seborrheic dermatitis in infants","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Cradle cap and seborrheic dermatitis in infants</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/contributors\" class=\"contributor contributor_credentials\">Denis Sasseville, MD, FRCPC</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/contributors\" class=\"contributor contributor_credentials\">Moise L Levy, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/contributors\" class=\"contributor contributor_credentials\">Joseph Fowler, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 06, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H608072793\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seborrheic dermatitis is a self-limiting eruption consisting of erythematous plaques with greasy-looking, yellowish scales distributed on areas rich in sebaceous glands such as the scalp, the external ear, the center of the face, and the intertriginous areas. </p><p>This topic will discuss cradle cap and seborrheic dermatitis in infants. Seborrheic dermatitis in adolescents and adults is discussed separately. (See <a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Seborrheic dermatitis in adolescents and adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H608072800\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Seborrheic dermatitis occurs in infants between the ages of 3 weeks and 12 months. It has been reported in about 10 percent of infants younger than one month [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/1\" class=\"abstract_t\">1</a>]. The prevalence peaks at the age of three months (about 70 percent) and decreases steadily in the following months, affecting about 7 percent of children aged one to two years [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/2\" class=\"abstract_t\">2</a>].</p><p class=\"headingAnchor\" id=\"H608072807\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of infantile seborrheic dermatitis is not known. Transplacental transfer of maternal androgens stimulates the growth of the infant's sebaceous glands, which are necessary but not sufficient for the development of seborrheic dermatitis. The role of Malassezia, a lipid-dependent yeast, is not clear; Malassezia colonization has been reported in infants with seborrheic dermatitis, infants with other dermatologic conditions, and in normal infants [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/3-5\" class=\"abstract_t\">3-5</a>].</p><p class=\"headingAnchor\" id=\"H608072814\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common manifestation of seborrheic dermatitis in newborns and infants is &quot;cradle cap,&quot; an asymptomatic and non-inflammatory accumulation of yellowish, greasy scales on the scalp (<a href=\"image.htm?imageKey=DERM%2F101267%7EDERM%2F101268\" class=\"graphic graphic_picture graphicRef101267 graphicRef101268 \">picture 1A-B</a>). The vertex and the frontal area are commonly involved. Sometimes the eruption starts on the face, with erythematous, scaly, salmon-colored plaques (<a href=\"image.htm?imageKey=DERM%2F101269\" class=\"graphic graphic_picture graphicRef101269 \">picture 2</a>). The forehead, the retroauricular areas, eyebrows and eyelids, cheeks, and nasolabial folds are commonly affected (<a href=\"image.htm?imageKey=DERM%2F101270\" class=\"graphic graphic_picture graphicRef101270 \">picture 3</a>). Seborrheic dermatitis may also occur in the napkin (diaper) area (<a href=\"image.htm?imageKey=DERM%2F73813\" class=\"graphic graphic_picture graphicRef73813 \">picture 4</a>), on the trunk, with a predilection for the umbilical area, or in the intertriginous areas. It also may occur simultaneously at multiple sites (<a href=\"image.htm?imageKey=DERM%2F52803\" class=\"graphic graphic_picture graphicRef52803 \">picture 5</a>). </p><p>In the folds around the neck, in the axillae, and the crural region, the lesions have a moist, glistening, nonscaly aspect and tend to be confluent. In more widespread forms, large areas of the trunk may become involved with sharply marginated plaques of erythema and scaling that cover the lower abdomen, pubic and groin area, as well as the buttocks. Rarely, seborrheic dermatitis may present as an erythrodermic eruption in infants [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/6,7\" class=\"abstract_t\">6,7</a>].</p><p>The infant is generally well; feeding and sleep are not disturbed. The pruritus is mild in most cases. The clinical manifestations fluctuate, but most cases eventually resolve spontaneously within weeks to a few months. Cases persisting beyond the age of 12 months are rare, and require the diagnosis to be reconsidered. (See <a href=\"#H608072842\" class=\"local\">'Differential diagnosis'</a> below.)</p><p class=\"headingAnchor\" id=\"H608072842\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of infantile seborrheic dermatitis includes:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atopic dermatitis</strong> &ndash; Atopic dermatitis is the other major dermatitis of infancy. It is characterized by severe pruritus that interferes with feeding and sleep. The erythematous, scaly, and crusted lesions of atopic dermatitis are generally poorly demarcated, and commonly involve the cheeks, scalp, and extensor surfaces of the limbs (<a href=\"image.htm?imageKey=DERM%2F77386%7EALLRG%2F77457%7EALLRG%2F56461\" class=\"graphic graphic_picture graphicRef77386 graphicRef77457 graphicRef56461 \">picture 6A-C</a>). The diaper area is usually spared (<a href=\"image.htm?imageKey=DERM%2F68746\" class=\"graphic graphic_picture graphicRef68746 \">picture 7</a>). A positive family history of eczema, asthma, and allergic rhinitis is often present. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis#H11\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Diaper dermatitis</strong> &ndash; Irritant diaper dermatitis is caused by the moist environment and friction of the diaper. In contrast to seborrheic dermatitis, it usually spares the skin folds. However, diaper dermatitis with superimposed Candida infection has a beefy red, glistening appearance, sometimes with superficial erosions, and involves the skin folds. Transient pustules may be seen at the advancing borders, and satellite lesions are common (<a href=\"image.htm?imageKey=DERM%2F64556\" class=\"graphic graphic_picture graphicRef64556 \">picture 8</a>). Infrequently, diaper dermatitis may spread beyond the diaper area and become disseminated, with a pattern resembling seborrheic dermatitis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Psoriasis</strong> &ndash; Psoriasis is uncommon in infants, but can mimic seborrheic dermatitis, especially when it involves the flexures or the diaper area. The psoriatic plaques are sharply defined, shiny and bright red in color, with the typical large, silvery scales of psoriasis usually seen in nonintertriginous areas (<a href=\"image.htm?imageKey=DERM%2F74892\" class=\"graphic graphic_picture graphicRef74892 \">picture 9</a>). (See <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis#H9\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of psoriasis&quot;, section on 'Clinical manifestations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pityriasis (tinea) amiantacea</strong> &ndash; In older children, pityriasis amiantacea (tinea amiantacea) may be an infrequent scalp reaction caused by psoriasis or seborrheic dermatitis. It presents with a thick accumulation of whitish hard scales on the scalp (<a href=\"image.htm?imageKey=DERM%2F58114\" class=\"graphic graphic_picture graphicRef58114 \">picture 10</a>). The scales are adherent to the scalp and cement the proximal part of the hair. Forcefully removing the scales pulls the hair with them. Treatment of pityriasis amiantacea involves frequent shampooing, repeated overnight application of emollients, and combing to remove scales. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Langerhans cell histiocytosis</strong> &ndash; Langerhans cell histiocytosis may present in infancy as a refractory seborrheic dermatitis or as diaper dermatitis with ulceration and erosion. Sometimes, papules and brownish-red or purpuric nodules can be seen on the scalp, retroauricular areas, axillae, and inguinocrural folds (<a href=\"image.htm?imageKey=DERM%2F57722%7EDERM%2F69504\" class=\"graphic graphic_picture graphicRef57722 graphicRef69504 \">picture 11A-B</a>). A skin biopsy will confirm the diagnosis. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tinea capitis</strong> &ndash; In infants, tinea capitis may present as a scaly scalp dermatitis with moderate or minimal inflammation (<a href=\"image.htm?imageKey=DERM%2F101271\" class=\"graphic graphic_picture graphicRef101271 \">picture 12</a>). Hair loss generally is present but is not always easy to detect. KOH examination of the hair shaft and fungal cultures will confirm the diagnosis. Tinea is rare in infants. </p><p/><p class=\"headingAnchor\" id=\"H608072935\"><span class=\"h1\">TREATMENT</span></p><p class=\"headingAnchor\" id=\"H710058552\"><span class=\"h2\">Cradle cap</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In infants, seborrheic dermatitis has a self-limited course and resolves spontaneously in weeks to several months. Therefore, we suggest that initial treatment should be conservative, including education and reassurance of parents, and simple skin care measures. </p><p>Conservative measures for scalp seborrheic dermatitis may include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Application of an emollient (white petrolatum, vegetable oil, <a href=\"topic.htm?path=mineral-oil-pediatric-drug-information\" class=\"drug drug_pediatric\">mineral oil</a>, baby oil) to the scalp (overnight, if necessary) to loosen the scales, followed by removal of scales with a soft brush (eg, a soft toothbrush) or fine-tooth comb </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Frequent shampooing with mild, non-medicated baby shampoo followed by removal of scales with a soft brush (eg, a soft toothbrush) or fine-tooth comb </p><p/><p>In more extensive or persistent cases, we suggest either a short course of low-potency topical corticosteroids (group seven (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 1</a>)) applied once per day for one week or <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream or shampoo twice per week for two weeks. Corticosteroids are preferred if there is a predominant inflammatory component; ketoconazole 2% cream or shampoo is an alternative in diffuse cases or if the use of topical corticosteroids is a concern for the parents. </p><p>There are no randomized trials of antifungal agents or topical corticosteroids for the treatment of cradle cap in infants.</p><p>A systematic review identified five randomized trials comparing topical antifungals with topical corticosteroids in adults with seborrheic dermatitis [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/8\" class=\"abstract_t\">8</a>]. All the studies indicated that the two treatments were equally effective. In a nonrandomized study of 48 children aged two weeks to two years, <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream was equivalent to 1% <a href=\"topic.htm?path=hydrocortisone-pediatric-drug-information\" class=\"drug drug_pediatric\">hydrocortisone</a> cream in clearing the lesions in two weeks [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/9\" class=\"abstract_t\">9</a>].</p><p>The use of lower potency topical corticosteroids in children is generally safe when used for short durations. (See <a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use#H10\" class=\"medical medical_review\">&quot;General principles of dermatologic therapy and topical corticosteroid use&quot;, section on 'Topical corticosteroids'</a>.)</p><p><a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">Ketoconazole</a> shampoo may cause eye irritation. Systemic absorption of topical ketoconazole in infants has been evaluated in two studies. In one, ketoconazole 2% shampoo used twice a week for four weeks in 13 infants (&lt;12 months) produced no detectable serum ketoconazole levels and no abnormalities of liver function tests [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/10\" class=\"abstract_t\">10</a>]. In the other, ketoconazole 2% cream was used once daily for 10 days to treat 19 children with seborrheic dermatitis of the scalp and diaper area. Peak plasma levels of ketoconazole detected one to three hours after topical treatment were 1 to 2 percent of those measured after systemic administration [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/11\" class=\"abstract_t\">11</a>]. </p><p>Other antiseborrheic shampoos (eg, <a href=\"topic.htm?path=selenium-sulfide-pediatric-drug-information\" class=\"drug drug_pediatric\">selenium sulfide</a> 2.5%, <a href=\"topic.htm?path=zinc-pyrithione-drug-information\" class=\"drug drug_general\">zinc pyrithione</a>, salicylic acid) have been used in the treatment of infantile seborrheic dermatitis. However, there are no clinical trials evaluating their efficacy and safety in infants. Observational studies in adults suggest that shampoos and ointments containing salicylic acid may result in systemic toxicity because of transcutaneous absorption [<a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/12\" class=\"abstract_t\">12</a>].</p><p class=\"headingAnchor\" id=\"H710058559\"><span class=\"h2\">Nonscalp, nonintertriginous seborrheic dermatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest that seborrheic dermatitis involving body areas other than the scalp in infants be treated with <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream (once a day for one to two weeks) or a low potency topical corticosteroid (eg, <a href=\"topic.htm?path=hydrocortisone-pediatric-drug-information\" class=\"drug drug_pediatric\">hydrocortisone</a> 1% cream once a day). The use of topical corticosteroids should be limited to the time needed to achieve the clearing of the lesions, but no longer than one week (see <a href=\"#H16968893\" class=\"local\">'Response to therapy'</a> below). Emollients can be used liberally. </p><p>There are no randomized trials evaluating the treatment of nonscalp seborrheic dermatitis in infants. A single randomized trial in adults suggested that <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream and mid-potency corticosteroids are equally effective. We generally use only low potency topical corticosteroids for seborrheic dermatitis in infants given the natural history of spontaneous resolution and the potential for systemic absorption of topical corticosteroids. (See <a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use#H14\" class=\"medical medical_review\">&quot;General principles of dermatologic therapy and topical corticosteroid use&quot;, section on 'Use in children'</a>.)</p><p class=\"headingAnchor\" id=\"H2573302\"><span class=\"h2\">Neck folds and other intertriginous areas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest that infants with seborrheic dermatitis of the intertriginous areas be treated with a topical azole (<a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream or other azole preparation, once a day for one to two weeks). In addition, topical creams or ointments containing <a href=\"topic.htm?path=zinc-oxide-pediatric-drug-information\" class=\"drug drug_pediatric\">zinc oxide</a> <span class=\"nowrap\">and/or</span> petrolatum may be applied liberally. Although there are no randomized trials evaluating this therapy, seborrheic dermatitis involving the intertriginous areas is frequently superinfected with Candida albicans. The topical barrier helps to limit skin maceration.</p><p class=\"headingAnchor\" id=\"H16968893\"><span class=\"h2\">Response to therapy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>If the rash does not improve after one week of corticosteroid therapy or two weeks of antifungal therapy as described above, the diagnosis should be reconsidered. (See <a href=\"#H608072842\" class=\"local\">'Differential diagnosis'</a> above.)</p><p>If the diagnosis of infantile seborrheic dermatitis is confirmed, intermittent courses of treatment may be needed, since the disease may recur for weeks to months before disappearing.</p><p class=\"headingAnchor\" id=\"H3613380296\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-seborrheic-dermatitis\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Seborrheic dermatitis&quot;</a>.) </p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=seborrheic-dermatitis-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Seborrheic dermatitis (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=seborrheic-dermatitis-including-dandruff-and-cradle-cap-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H29306861\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Seborrheic dermatitis in infants is a common and self-limited condition most frequently involving the scalp (cradle cap (<a href=\"image.htm?imageKey=PEDS%2F55801\" class=\"graphic graphic_picture graphicRef55801 \">picture 13</a>)). (See <a href=\"#H608072814\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The initial treatment of scalp seborrheic dermatitis includes education, reassurance, and conservative measures (emollients and frequent shampooing) to soften and remove the scales. If conservative measures fail, we suggest either topical low potency corticosteroids (group seven (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 1</a>)) or <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% shampoo or cream (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Topical corticosteroid is applied once per day for one week. Ketoconazole 2% shampoo or cream is used twice per week for two weeks. (See <a href=\"#H710058552\" class=\"local\">'Cradle cap'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For seborrheic dermatitis of areas other than the scalp, we suggest <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream or a low-potency corticosteroid cream (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 1</a>) (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Ketoconazole 2% cream should be applied once a day for one to two weeks. Topical corticosteroid is applied once a day for up to one week. (See <a href=\"#H710058559\" class=\"local\">'Nonscalp, nonintertriginous seborrheic dermatitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For seborrheic dermatitis of the intertriginous areas, we suggest <a href=\"topic.htm?path=ketoconazole-pediatric-drug-information\" class=\"drug drug_pediatric\">ketoconazole</a> 2% cream or other azole cream (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). The azole cream is applied once a day for one to two weeks. In addition, topical creams or ointments containing <a href=\"topic.htm?path=zinc-oxide-pediatric-drug-information\" class=\"drug drug_pediatric\">zinc oxide</a> <span class=\"nowrap\">and/or</span> petrolatum may be applied liberally. (See <a href=\"#H2573302\" class=\"local\">'Neck folds and other intertriginous areas'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>If the rash does not resolve or improve considerably after one week of corticosteroid therapy or two weeks of antifungal therapy as described above, the diagnosis should be reconsidered (see <a href=\"#H608072842\" class=\"local\">'Differential diagnosis'</a> above). If the diagnosis of infantile seborrheic dermatitis is confirmed, intermittent courses of treatment may be needed, since the disease may recur for weeks to months before disappearing.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/1\" class=\"nounderline abstract_t\">Sachdeva M, Kaur S, Nagpal M, Dewan SP. Cutaneous lesions in new born. Indian J Dermatol Venereol Leprol 2002; 68:334.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/2\" class=\"nounderline abstract_t\">Foley P, Zuo Y, Plunkett A, et al. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 2003; 139:318.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/3\" class=\"nounderline abstract_t\">Ruiz-Maldonado R, L&oacute;pez-Mat&iacute;nez R, P&eacute;rez Chavarr&iacute;a EL, et al. Pityrosporum ovale in infantile seborrheic dermatitis. Pediatr Dermatol 1989; 6:16.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/4\" class=\"nounderline abstract_t\">Broberg A, Faergemann J. Infantile seborrhoeic dermatitis and Pityrosporum ovale. Br J Dermatol 1989; 120:359.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/5\" class=\"nounderline abstract_t\">Wananukul S, Chindamporn A, Yumyourn P, et al. Malassezia furfur in infantile seborrheic dermatitis. Asian Pac J Allergy Immunol 2005; 23:101.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/6\" class=\"nounderline abstract_t\">Sarkar R, Garg VK. Erythroderma in children. Indian J Dermatol Venereol Leprol 2010; 76:341.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/7\" class=\"nounderline abstract_t\">Al-Dhalimi MA. Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol 2007; 34:302.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/8\" class=\"nounderline abstract_t\">Cohen S. Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? Arch Dis Child 2004; 89:288.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/9\" class=\"nounderline abstract_t\">Wannanukul S, Chiabunkana J. Comparative study of 2% ketoconazole cream and 1% hydrocortisone cream in the treatment of infantile seborrheic dermatitis. J Med Assoc Thai 2004; 87 Suppl 2:S68.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/10\" class=\"nounderline abstract_t\">Brodell RT, Patel S, Venglarcik JS, et al. The safety of ketoconazole shampoo for infantile seborrheic dermatitis. Pediatr Dermatol 1998; 15:406.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/11\" class=\"nounderline abstract_t\">Taieb A, Legrain V, Palmier C, et al. Topical ketoconazole for infantile seborrhoeic dermatitis. Dermatologica 1990; 181:26.</a></li><li><a href=\"https://www.uptodate.com/contents/cradle-cap-and-seborrheic-dermatitis-in-infants/abstract/12\" class=\"nounderline abstract_t\">Morra P, Bartle WR, Walker SE, et al. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother 1996; 30:935.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 16261 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H29306861\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H608072793\" id=\"outline-link-H608072793\">INTRODUCTION</a></li><li><a href=\"#H608072800\" id=\"outline-link-H608072800\">EPIDEMIOLOGY</a></li><li><a href=\"#H608072807\" id=\"outline-link-H608072807\">PATHOGENESIS</a></li><li><a href=\"#H608072814\" id=\"outline-link-H608072814\">CLINICAL MANIFESTATIONS</a></li><li><a href=\"#H608072842\" id=\"outline-link-H608072842\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H608072935\" id=\"outline-link-H608072935\">TREATMENT</a><ul><li><a href=\"#H710058552\" id=\"outline-link-H710058552\">Cradle cap</a></li><li><a href=\"#H710058559\" id=\"outline-link-H710058559\">Nonscalp, nonintertriginous seborrheic dermatitis</a></li><li><a href=\"#H2573302\" id=\"outline-link-H2573302\">Neck folds and other intertriginous areas</a></li><li><a href=\"#H16968893\" id=\"outline-link-H16968893\">Response to therapy</a></li></ul></li><li><a href=\"#H3613380296\" id=\"outline-link-H3613380296\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H13010581\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H29306861\" id=\"outline-link-H29306861\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/16261|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/101267\" class=\"graphic graphic_picture\">- Cradle cap</a></li><li><a href=\"image.htm?imageKey=DERM/101268\" class=\"graphic graphic_picture\">- Cradle cap dark skin</a></li><li><a href=\"image.htm?imageKey=DERM/101269\" class=\"graphic graphic_picture\">- Infantile seborrheic dermatitis face</a></li><li><a href=\"image.htm?imageKey=DERM/101270\" class=\"graphic graphic_picture\">- Infantile seborrheic dermatitis forehead</a></li><li><a href=\"image.htm?imageKey=DERM/73813\" class=\"graphic graphic_picture\">- Seborrheic dermatitis diaper area</a></li><li><a href=\"image.htm?imageKey=DERM/52803\" class=\"graphic graphic_picture\">- Infantile seborrheic dermatitis multiple sites</a></li><li><a href=\"image.htm?imageKey=DERM/77386\" class=\"graphic graphic_picture\">- Atopic dermatitis infant 2</a></li><li><a href=\"image.htm?imageKey=ALLRG/77457\" class=\"graphic graphic_picture\">- Infantile atopic dermatitis widespread</a></li><li><a href=\"image.htm?imageKey=ALLRG/56461\" class=\"graphic graphic_picture\">- Atopic dermatitis infantile II</a></li><li><a href=\"image.htm?imageKey=DERM/68746\" class=\"graphic graphic_picture\">- Atopic dermatitis infant</a></li><li><a href=\"image.htm?imageKey=DERM/64556\" class=\"graphic graphic_picture\">- Diaper dermatitis candidiasis</a></li><li><a href=\"image.htm?imageKey=DERM/74892\" class=\"graphic graphic_picture\">- Infantile psoriasis</a></li><li><a href=\"image.htm?imageKey=DERM/58114\" class=\"graphic graphic_picture\">- Pityriasis tinea amiantacea</a></li><li><a href=\"image.htm?imageKey=DERM/57722\" class=\"graphic graphic_picture\">- Langerhans histiocytosis skin 1</a></li><li><a href=\"image.htm?imageKey=DERM/69504\" class=\"graphic graphic_picture\">- Langerhans histiocytosis skin 2</a></li><li><a href=\"image.htm?imageKey=DERM/101271\" class=\"graphic graphic_picture\">- Tinea capitis infant</a></li><li><a href=\"image.htm?imageKey=PEDS/55801\" class=\"graphic graphic_picture\">- Seborrheic dermatitis peds</a></li></ul></li><li><div id=\"DERM/16261|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/62402\" class=\"graphic graphic_table\">- Topical corticosteroids</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=general-principles-of-dermatologic-therapy-and-topical-corticosteroid-use\" class=\"medical medical_review\">General principles of dermatologic therapy and topical corticosteroid use</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-the-basics\" class=\"medical medical_basics\">Patient education: Seborrheic dermatitis (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-including-dandruff-and-cradle-cap-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Seborrheic dermatitis (including dandruff and cradle cap) (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seborrheic-dermatitis-in-adolescents-and-adults\" class=\"medical medical_review\">Seborrheic dermatitis in adolescents and adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-seborrheic-dermatitis\" class=\"medical medical_society_guidelines\">Society guideline links: Seborrheic dermatitis</a></li></ul></div></div>","javascript":null}